CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,571 enrolled
Drug / intervention
TOF-Watch SX® Monitoring of NMBdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01871064
NCT01871064N/ACompleted

Residual Curarization and Its Incidence at Tracheal Extubation in China

Xinmin Wu·observational·Posted Jun 6, 2013·Updated Nov 10, 2015

In Brief

An observational study evaluating TOF-Watch SX® Monitoring of NMB for Residual Curarization. Completed, enrolled 1,571 participants across 32 sites.

Detailed Summary

This study will assess the residual neuromuscular blockade (NMB) Train-Of-Four (TOF) ratios at tracheal extubation when anesthesiologists have determined that full recovery of neuromuscular function has occurred using standard clinical criteria for participants whose non-depolarizing-induced NMB is either not reversed or reversed with an acetylcholinesterase inhibitor administered as per standard routine care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesChina

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 6, 2013
Enrollment StartDec 1, 2012
Primary CompletionSep 1, 2013
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 13.1 years ago

Interventions

TOF-Watch SX® Monitoring of NMBdevice

Participants will have the extent of NMB monitored by a TOF-Watch SX®.